Phase I, Randomised, 2-period, Crossover Pharmacokinetic study of Buprenorphine Transdermal Patch 5, 10, or 20 mg in healthy volunteers
Latest Information Update: 07 Dec 2017
At a glance
- Drugs Buprenorphine (Primary)
- Indications Pain
- Focus Adverse reactions; Pharmacokinetics
- 07 Dec 2017 New trial record